Bioqual Return on Tangible Equity 2010-2025 | BIOQ
Current and historical return on tangible equity values for Bioqual (BIOQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Bioqual Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2025-02-28 |
$0.00B |
$0.04B |
-5.63% |
| 2024-11-30 |
$0.00B |
$0.03B |
-8.28% |
| 2024-08-31 |
$0.00B |
$0.04B |
-5.37% |
| 2024-05-31 |
$0.00B |
$0.04B |
0.00% |
| 2024-02-29 |
$0.00B |
$0.04B |
0.00% |
| 2023-11-30 |
$0.00B |
$0.04B |
-2.68% |
| 2023-08-31 |
$0.00B |
$0.04B |
0.00% |
| 2023-05-31 |
$0.00B |
$0.04B |
0.00% |
| 2023-02-28 |
$0.00B |
$0.04B |
8.00% |
| 2022-11-30 |
$0.01B |
$0.04B |
13.51% |
| 2022-08-31 |
$0.01B |
$0.04B |
13.89% |
| 2022-05-31 |
$0.01B |
$0.04B |
14.29% |
| 2022-02-28 |
$0.01B |
$0.04B |
14.71% |
| 2021-11-30 |
$0.01B |
$0.03B |
15.27% |
| 2021-08-31 |
$0.01B |
$0.03B |
15.87% |
| 2021-05-31 |
$0.01B |
$0.03B |
19.83% |
| 2021-02-28 |
$0.01B |
$0.03B |
17.39% |
| 2020-11-30 |
$0.01B |
$0.03B |
18.02% |
| 2020-08-31 |
$0.01B |
$0.03B |
18.69% |
| 2020-05-31 |
$0.00B |
$0.03B |
20.51% |
| 2020-02-29 |
$0.00B |
$0.03B |
33.33% |
| 2019-11-30 |
$0.00B |
$0.03B |
54.55% |
| 2019-08-31 |
$0.00B |
|
-400.00% |
| 2019-05-31 |
$0.00B |
$0.00B |
-400.00% |
| 2019-02-28 |
$0.00B |
|
57.14% |
| 2018-11-30 |
$0.00B |
|
76.19% |
| 2018-08-31 |
$0.00B |
|
76.19% |
| 2018-05-31 |
$0.00B |
$0.02B |
76.19% |
| 2018-02-28 |
$0.00B |
|
0.00% |
| 2017-11-30 |
$0.00B |
|
0.00% |
| 2017-08-31 |
$0.00B |
|
0.00% |
| 2017-05-31 |
$0.00B |
|
0.00% |
| 2017-02-28 |
$0.00B |
|
0.00% |
| 2016-11-30 |
$0.00B |
|
0.00% |
| 2016-08-31 |
$0.00B |
|
0.00% |
| 2016-05-31 |
$0.00B |
|
0.00% |
| 2016-02-29 |
$0.00B |
|
0.00% |
| 2015-11-30 |
$0.00B |
|
0.00% |
| 2015-08-31 |
$0.00B |
|
0.00% |
| 2015-05-31 |
$0.00B |
|
0.00% |
| 2015-02-28 |
$0.00B |
|
0.00% |
| 2014-08-31 |
$0.00B |
|
0.00% |
| 2014-05-31 |
$0.00B |
|
0.00% |
| 2013-11-30 |
$0.00B |
|
0.00% |
| 2013-08-31 |
$0.00B |
|
0.00% |
| 2013-05-31 |
$0.00B |
|
0.00% |
| 2012-05-31 |
$0.00B |
|
0.00% |
| 2012-02-29 |
$0.00B |
|
0.00% |
| 2011-11-30 |
$0.00B |
|
0.00% |
| 2011-08-31 |
$0.00B |
|
0.00% |
| 2011-05-31 |
$0.00B |
|
0.00% |
| 2011-02-28 |
$0.00B |
|
0.00% |
| 2010-11-30 |
$0.00B |
|
0.00% |
| 2010-08-31 |
$0.00B |
|
0.00% |
| 2010-05-31 |
$0.00B |
|
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.039B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
